Skip to main content
Equibles

Driehaus Capital Management LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 938206 Chicago, IL
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,455,716
+$13,863,276 QoQ
Shares Held
118,497
+0.3% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#45
of 415 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. LGND ranks #22 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5 CRNX
Crinetics Pharmaceuticals, Inc.
 6,463,551 $241,866,078
6 APGE
Apogee Therapeutics, Inc.
 1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in LGND

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,455,716 118,497
2026-03-31 $23,592,440 118,169
2025-12-31 $23,128,176 122,326
2025-09-30 $28,838,569 162,801
2025-06-30 $18,320,896 161,162
2025-03-31 $17,050,553 162,170
2024-12-31 $17,440,912 162,771
2024-09-30 $9,582,416 95,738